Abstract: A battery module includes: a stack including a plurality of battery cells arranged side by side in a first direction. A reference plane for positioning the stack in a direction orthogonal to the first direction is provided. The cover member includes a biasing portion that biases the stack in a direction away from the cover member. The biasing portion biases the stack to press the stack against the reference plane.

Abstract: A battery module includes: a stack including a plurality of battery cells arranged side by side in a first direction; and a cover member having an insulating property, the cover member being provided to cover the stack from a side opposite to the electrode terminal. The cover member includes a first drainage portion located at a center portion of the cover member in a second direction orthogonal to the first direction, and a second drainage portion located at each of both end portions of the cover member in the second direction.

Abstract: A cover body has: a plurality of divided cover portions arranged side by side in a Y axis direction; an elastic deformation portion extending between the divided cover portions adjacent to each other; a first connection portion provided in a first divided cover portion disposed at one end portion in the Y axis direction, the first connection portion being connected to the attachment-target member so as to be fixed in the Y axis direction; a second connection portion provided in a second divided cover portion disposed at the other end portion in the Y axis direction, the second connection portion being connected to the attachment-target member so as to be fixed in the Y axis direction; and a third connection portion disposed between the first connection portion and the second connection portion and connected to the attachment-target member so as to be slidable in the Y axis direction.

Abstract: A battery module includes: a plurality of stacked battery cells; a first cover body and a second cover body provided to cover the plurality of battery cells in a direction orthogonal to a stacking direction of the battery cells; a pair of binding bars that restrain the plurality of battery cells in the stacking direction of the battery cells; and a retainer connected to each of the binding bars. The first cover body has a first overlapping portion. The second cover body has a second overlapping portion disposed between each of the battery cells and the first overlapping portion and overlapping with the first overlapping portion in a direction orthogonal to the stacking direction of the battery cells. The first cover body is disposed between each of the battery cells and the retainer in the direction orthogonal to the stacking direction of the battery cells.

Abstract: A particle comprising a first fraction containing an active ingredient and a second fraction containing a surfactant, and having a number average particle diameter of from 1 to 100 nm.

Abstract: The present invention provides a core-shell structure having high skin permeability. The core-shell structure includes a core portion containing a hydrophilic drug having a molecular weight of 400 or more; and a shell portion containing a surfactant, and the core portion is a solid, the hydrophilic drug has a water-octanol partition coefficient of ?3 or more and 6 or less, the surfactant has an alkyl group or an alkenyl group having 10 to 20 carbon atoms, and a mass ratio between the hydrophilic drug and the surfactant (hydrophilic drug:surfactant) is 1:5 to 1:20.

Abstract: Problem to be Solved There is provided a formulation including a particle containing an active ingredient and a surfactant, wherein morphological stability is excellent. Solution A particle containing an active ingredient, a surfactant and a pH adjuster.

Abstract: Provided are an active ingredient-containing particle with improved shape retainability. The particle includes a first fraction containing an active ingredient, a second fraction containing a surfactant, and at least one water-soluble polymer selected from the group consisting of a polysaccharide and a polymer having 2-methacryloyloxyethyl phosphorylcholine as a constituent unit.

Abstract: An object is to provide a formulation that includes a particle containing an active ingredient and a surfactant, and a base, and is more excellent in storage stability. For solution, a formulation including a particle containing an active ingredient and a surfactant, and a base, in which the surfactant is contained in a ratio of 5 to 100 parts by weight based on 1 part by weight of the active ingredient, is provided.

Abstract: Provided are an active ingredient-containing particle with improved shape retainability. The particle includes a first fraction containing an active ingredient, a second fraction containing a surfactant, and at least one water-soluble polymer selected from the group consisting of a polysaccharide and a polymer having 2-methacryloyloxyethyl phosphorylcholine as a constituent unit.

Abstract: An object of the present invention is to prevent a particle including a first fraction containing an active ingredient and a second fraction containing a surfactant from bleeding out from the base phase of an external preparation. The external preparation comprises a particle including a first fraction containing an active ingredient and a second fraction containing a surfactant, and a base phase containing a gelatinous liquid component.

Abstract: The present invention provides a core-shell structure having high skin permeability. The core-shell structure includes a core portion containing a hydrophilic drug having a molecular weight of 400 or more; and a shell portion containing a surfactant, and the core portion is a solid, the hydrophilic drug has a water-octanol partition coefficient of ?3 or more and 6 or less, the surfactant has an alkyl group or an alkenyl group having 10 to 20 carbon atoms, and a mass ratio between the hydrophilic drug and the surfactant (hydrophilic drug:surfactant) is 1:5 to 1:20.

Abstract: A particle comprising a first fraction containing an active ingredient and a second fraction containing a surfactant, and having a number average particle diameter of from 1 to 100 nm.

Abstract: An object is to provide a formulation that includes a particle containing an active ingredient and a surfactant, and a base, and is more excellent in storage stability. For solution, a formulation including a particle containing an active ingredient and a surfactant, and a base, in which the surfactant is contained in a ratio of 5 to 100 parts by weight based on 1 part by weight of the active ingredient, is provided.

Abstract: There is provided a method of vacuum evaporation comprising causing evaporated material (5) from vacuum evaporation source (20) furnished with container (1) with its one side open accommodating organic material (2) to form a film on opposed substrate (7), wherein the vacuum evaporation source has heating element (3) not fixed to the container, and being in contact with the surface of organic material held in the container, and wherein the organic material is evaporated by heating of the heating element only, the evaporated material released through at least one hole (6) or at least one slit made in the heating element.

Abstract: There is provided a method of vacuum evaporation comprising causing evaporated material (5) from vacuum evaporation source (20) furnished with container (1) with its one side open accommodating organic material (2) to form a film on opposed substrate (7), wherein the vacuum evaporation source has heating element (3) not fixed to the container, sealing the opening of the container and being in contact with the surface of organic material held in the container, and wherein the organic material is evaporated by heating of the heating element only, the evaporated material released through at least one hole (6) or at least one slit made in the heating element.

Abstract: The object of the present invention is to provide a dermal composition for external use which keeps skin healthy and demonstrates a sufficient effect in treating skin diseases. The present invention relates to a dermal composition for external use, which comprises sodium cromoglycate and a monoester of polyvalent alcohol and salicylic acid contained in a base.

Abstract: The object of the present invention is to provide a dermal composition for external use which keeps skin healthy and demonstrates a sufficient effect in treating skin diseases. The present invention relates to a dermal composition for external use, which comprises sodium cromoglycate and a monoester of polyvalent alcohol and salicylic acid contained in a base.

Abstract: It is intended to provide a novel instrument for inducing a cytokine and a method of inducing a cytokine by which a cytokine can be effectively induced compared to the existing cytokine induction therapy. Namely, an instrument for inducing a cytokine which contains a hemolytic streptococcus and/or a hemolytic streptococcus-origin component and a water-insoluble carrier; and a method of inducing a cytokine by using this instrument for inducing a cytokine.

Abstract: The object of the present invention is to provide a dermal composition for external use which keeps skin healthy and demonstrates a sufficient effect in treating skin diseases.